徐州威格顿生物科技有限公司
威格顿生物
Weigedun Biotechnology
KIAA1755 Mouse mAb
规格信息
| 规格 | 货号 |
|---|---|
| 50ul | WGD-Z-2611662 |
| 100ul | WGD-Z-2611662 |
详细参数
| 别名 | Uncharacterized protein KIAA1755 |
| 基因名 | KIAA1755 |
| UniProt ID | Q5JYT7 |
| 反应种属 | Human |
| 应用 | IHC-P |
| 宿主 | Mouse |
| 偶联物 | Unconjugated |
| 修饰 | Unmodified |
| 亚型 | IgG2b |
| 克隆号 | 2Y5-R5-N1 |
| 克隆性 | Monoclonal Antibody |
| 分子量 | Calculated MW: 130 kDa |
| 纯化方式 | Affinity Purified |
| 产品形式 | Liquid |
| 推荐稀释比 | IHC-1:100-1:200 |
| 存储缓冲液 | Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.09% sodium azide |
| 保存温度 | Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles. |
| 背景信息 | KIAA1755 is an uncharacterized human protein consisting of 1,200 amino acids. KIAA1755 is associated with a wide range of functional interactions, including co-expression with other genes and involvement in pathways related to molecular profiles, phenotypes, and cellular structures. It shows differential expression across various tissues and cell types, as indicated by proteomic and epigenomic datasets. The protein has been linked to histone modification and DNA methylation patterns, suggesting a potential role in gene regulation and chromatin dynamics. On the disease front, mutations in KIAA1755 have been observed but are generally classified as likely benign, it has been studied for its mutation profile in cancer-related datasets. |